Home>Mutual Funds>Compare>Compare Nippon India Pharma Fund Direct Growth with SBI Healthcare Opportunities Fund Direct Plan Growth
shareSHARE
Compare Funds
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
cancel

Nippon India Pharma Fund Direct Growth

Equity
Sectoral/Thematic
5.0 star
INVEST NOW
cancel

SBI Healthcare Opportunities Fund Direct Plan Growth

Equity
Sectoral/Thematic
3.0 star
INVEST NOW
add_circle_outline

Add a fund

Nippon India Pharma Fund Direct Growth

(57.2%)

SBI Healthcare Opportunities Fund Direct Plan Growth

(54.5%)
1Y
3Y
5Y
Fund Details
keyboard_arrow_up
RiskVery HighVery High-
Min SIP Amount₹100₹500-
Expense Ratio1.04%1.12%-
NAV₹285.8 (09-Apr-2021)₹224.0 (09-Apr-2021)-
Fund Started01-Jan-201301-Jan-2013-
Fund Size₹4,261Cr₹1,564Cr-
Returns
keyboard_arrow_up
1Y
57.2%
54.5%
-
3Y
25.7%
20.9%
-
5Y
16.1%
9.8%
-
Pros & Cons
keyboard_arrow_up
Pros
1. 1Y Returns are higher than the category average returns
2. 3Y Returns are higher than the category average returns
3. 5Y Returns are higher than the category average returns
1. 1Y Returns are higher than the category average returns
-
Cons
Found nothing so far.
1. 5Y Returns are lower than the category average returns
-

Holding Analysis

keyboard_arrow_up
Top 5
-
-
-
Top 20
-
-
-
P/E
-
-
-
P/B
-
-
-
Turn Over
-
-
-
Equity
NaN%
NaN%
NaN%
Cash
NaN%
NaN%
NaN%

Top Holdings

keyboard_arrow_up
Top 10 Holdings
Name
Assets
Sun Pharmaceutical Inds. Ltd.
11.2%
Aurobindo Pharma Ltd.
9.9%
Dr. Reddy's Laboratories Ltd.
9.8%
Cipla Ltd.
9.8%
Lupin Ltd.
9.6%
Divi's Laboratories Ltd.
8.9%
Fortis Healthcare Ltd.
7.3%
Gland Pharma Ltd.
6.4%
Cadila Healthcare Ltd.
5.6%
Thyrocare Technologies Ltd.
3.9%
Name
Assets
Sun Pharmaceutical Inds. Ltd.
10.7%
Dr. Reddy's Laboratories Ltd.
10.1%
Lupin Ltd.
9.8%
Cipla Ltd.
9.4%
Aurobindo Pharma Ltd.
9.0%
Divi's Laboratories Ltd.
8.3%
Alkem Laboratories Ltd.
4.4%
Narayana Hrudayalaya Ltd.
4.2%
Strides Pharma Science Ltd.
4.0%
Abbott India Ltd.
3.8%
-
Fund Manager
keyboard_arrow_up
Name
Sailesh Raj Bhan
Tanmaya Desai
-
Education

Mr. Bhan is an MBA (Finance) and CFA.

Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).

-

Experience

Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.

Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.

-

About Fund
keyboard_arrow_up
Description

Reliance Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹2,32,169 Cr. Its ranked at 3 as per total assets at end of 30th Sep 2017.

SBI Mutual Fund started their mutual fund on 29/06/1987 and its managing total assets of ₹1,88,455 Cr. Its ranked at 5 as per total assets at end of 30th Sep 2017.

-

Launch Date
30 Jun 1995
29 Jun 1987
-
Custodian
Deutsche Bank
SBI SG Global Securities Services Pvt.Ltd.
-
Registrar & Transfer Agent
KFin Tech
Cams
-

Popular Comparisons

Motilal Oswal Multicap 35 Fund - Direct - Growth
17.8%
3Y Returns
VS
SBI Magnum Multi Cap Fund - Direct - Growth
16.3%
3Y Returns
Axis Bluechip Fund - Direct - Growth
17.4%
3Y Returns
VS
SBI Bluechip Fund - Direct - Growth
13.6%
3Y Returns
HDFC Small Cap Fund - Direct - Growth
22.9%
3Y Returns
VS
L&T Emerging Businesses Fund - Direct - Growth
22.4%
3Y Returns
ⓒ 2016-2021 Groww. All rights reserved, Built with in India